Literature DB >> 31236076

Minimally Invasive Endovascular Repair of Ascending Thoracic Aortic Aneurysm with Use of Local Anesthesia and Conscious Sedation.

Abdelkader Almanfi, Zvonimir Krajcer.   

Abstract

Ascending thoracic aortic aneurysm (ATAA) is typically treated surgically. No commercially available device has been specifically designed for endovascular ATAA repair, and currently, multiple anatomic and technical challenges affect its feasibility. Previously, such repairs have been performed with the patients under general anesthesia. We describe a novel, minimally invasive approach to endovascular repair of ATAA, involving local anesthesia, conscious sedation, and 24-hour hospitalization. Two consecutive male patients (ages, 79 and 54 yr) who had comorbidities underwent percutaneous transfemoral endovascular ATAA repair with use of commercially available endografts. Patient 1 had a saccular aneurysm, and Patient 2 had a pseudoaneurysm consequent to recent surgical ATAA repair. The patients were discharged from the hospital 24 hours after technically successful, uncomplicated procedures. At 2 months, computed tomograms showed no endoleak or stent-graft migration. Our experience shows that minimally invasive endovascular ATAA repair is feasible for selected high-risk patients. We describe the procedure, access and closure devices, and challenges associated with this approach.

Entities:  

Keywords:  Anesthesia, local; aortic aneurysm, thoracic/therapy; blood vessel prosthesis implantation/instrumentation; endovascular procedures/instrumentation/methods; equipment design; length of stay; patient selection; stents; treatment outcome

Year:  2019        PMID: 31236076      PMCID: PMC6555279          DOI: 10.14503/THIJ-17-6558

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  1 in total

1.  Percutaneous endovascular abdominal aortic aneurysm repair with monitored anesthesia care decreases operative time but not pulmonary complications.

Authors:  Joshua P Kronenfeld; Emily L Ryon; Alex Lall; Naixin Kang; Stefan Kenel-Pierre; Hilene DeAmorim; Jorge Rey; John Karwowski; Arash Bornak
Journal:  Vascular       Date:  2021-05-03       Impact factor: 1.105

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.